Both Lopid and Tricor are thought to work by targeting a molecular signal called the peroxisome proliferators activator receptor (PPAR) alpha.

FORBES

"My vision is that we will have drugs targeting key elements of molecular pathways" that go awry in disease, Fishman says.

FORBES: Magazine Article

SU-11248 is one of a new spate of cancer pills that work by targeting several of the molecular defects that cause the disease at one time.

FORBES: Pfizer Cancer Pill Proves Effective